Inuvo (INUV) director granted 3,000 restricted stock units as equity award
Rhea-AI Filing Summary
Inuvo, Inc. reported that one of its directors acquired equity-based compensation in the form of derivative securities. On 01/02/2026, the director received 3,000 restricted stock units, each representing a contingent right to receive one share of Inuvo common stock. The restricted stock units were acquired at a price of $0.0000 per unit and are listed as directly owned derivative securities. Following this grant, the director beneficially owns 3,000 derivative securities tied to Inuvo common stock, with the units shown as exercisable and expiring on 01/04/2027.
Positive
- None.
Negative
- None.
FAQ
What insider transaction did Inuvo (INUV) report in this Form 4 filing?
The filing shows that an Inuvo director acquired 3,000 restricted stock units on 01/02/2026, each linked to one share of Inuvo common stock.
What type of security did the Inuvo director receive and what does it represent?
The director received restricted stock units, each representing a contingent right to receive one share of Inuvo’s common stock.
At what price were the 3,000 restricted stock units granted to the Inuvo director?
The 3,000 restricted stock units were granted at a price of $0.0000 per unit, indicating they were awarded as equity compensation rather than purchased.
How many derivative securities does the Inuvo director beneficially own after this transaction?
After the reported transaction, the director beneficially owns 3,000 derivative securities in the form of restricted stock units tied to Inuvo common stock.
When are the Inuvo director’s restricted stock units exercisable and when do they expire?
The restricted stock units are shown with a date exercisable of 01/04/2027 and an expiration date of 01/04/2027 in the derivative securities table.
Is the reporting person a director or officer of Inuvo (INUV)?
The relationship section identifies the reporting person as a Director of Inuvo, Inc., with that box checked on the form.